I've developed gynecomastia after using Sustanon (a compound containing three types of testosterone), which is alleviated by Arimidex (anastrozole), what are the implications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gynecomastia Management with Arimidex (Anastrozole) in Sustanon Users

Anastrozole (Arimidex) is an effective treatment for gynecomastia caused by testosterone compounds like Sustanon, as it reduces estrogen levels by inhibiting the aromatase enzyme that converts testosterone to estrogen. 1

Mechanism of Gynecomastia with Testosterone Use

  • Sustanon, a compound containing multiple testosterone esters, can cause gynecomastia due to peripheral conversion of testosterone to estradiol by the aromatase enzyme 2
  • The imbalance between estrogen and androgen tissue levels is the primary mechanism behind gynecomastia development 3
  • When using exogenous testosterone, increased substrate (testosterone) leads to increased conversion to estradiol in peripheral tissues, particularly adipose tissue 4

How Anastrozole Works for Gynecomastia

  • Anastrozole is a selective non-steroidal aromatase inhibitor that significantly lowers serum estradiol concentrations 1
  • At a dose of 1 mg daily, anastrozole reduces estradiol by approximately 70% within 24 hours and by approximately 80% after 14 days 1
  • By reducing estrogen levels, anastrozole helps correct the estrogen-androgen imbalance that causes gynecomastia 3

Effectiveness for Testosterone-Induced Gynecomastia

  • Anastrozole has been shown to reduce breast size in patients with gynecomastia 3
  • Breast tenderness typically resolves within 4 weeks of starting anastrozole treatment 3
  • The effectiveness of anastrozole is greater when treatment is initiated early in the development of gynecomastia 3

Dosing Considerations

  • The typical dose of anastrozole for gynecomastia management is 1 mg daily 1
  • Lower doses (0.5 mg daily or 1 mg every other day) may be effective for some individuals while minimizing side effects 3
  • Treatment duration varies based on individual response, but is typically continued as long as the aromatizing substance (Sustanon) is being used 2

Potential Side Effects and Risks

  • Joint stiffness and arthralgias are common side effects of anastrozole 5
  • Anastrozole can cause bone mineral density loss and increase fracture risk 5
  • Other potential side effects include:
    • Vasomotor symptoms (hot flashes) 5
    • Hypertension 5
    • Dry eyes 5
    • Vaginal dryness (not applicable in males) 5
    • Elevated cholesterol levels 5

Monitoring Recommendations

  • Baseline assessment of bone mineral density should be considered for long-term use 5
  • Regular monitoring of estradiol and testosterone levels can help optimize dosing 3
  • Liver function tests should be monitored periodically as aromatase inhibitors can rarely cause hepatotoxicity 6

Alternative Approaches

  • Tamoxifen (a selective estrogen receptor modulator) is another option for treating gynecomastia 2
  • Discontinuing the testosterone compound is the most effective approach if possible 2
  • For established gynecomastia that doesn't respond to medical therapy, surgical removal may be necessary 7

Important Considerations

  • Using anastrozole without medical supervision while taking anabolic steroids carries risks 6
  • Completely suppressing estrogen can lead to adverse effects including bone loss, cognitive issues, and lipid abnormalities 6
  • The long-term safety of anastrozole use in healthy males has not been well-established 6

When to Seek Medical Attention

  • If gynecomastia is severe, rapidly progressing, or associated with pain 8
  • If other symptoms develop such as testicular abnormalities or nipple discharge 8
  • For proper dosing guidance and monitoring of hormone levels and side effects 8

References

Research

Drug-induced gynecomastia.

Expert opinion on drug safety, 2008

Research

Gynecomastia and hormones.

Endocrine, 2017

Guideline

Anastrozol-Associated Articular Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of gynecomastia.

Current opinion in investigational drugs (London, England : 2000), 2001

Research

Gynecomastia.

Indian journal of pediatrics, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.